BSEBoard Meeting21 Jul 2026 · 21 Jul 2026, 01:24 pm
Vivanta Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited Standalone and ....
Vivanta Industries Ltd · 541735
✦ AI SummaryResults
Vivanta Industries Ltd has scheduled a board meeting on 24/07/2026 to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30/06/2026, along with a limited review report.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vivanta Industries Ltd - 541735 - Board Meeting Intimation for Financial Results For The Quarter Ended On 30Th June, 2026, Along With The Limited Review Report
Attachments (1)
📄pdf
Download →
ee748f85-5044-4cd7-851c-3751e99b854c.pdf
View document text
Date: 21st July 2026
BSE Limited,
Dept. of Corporate Services,
BSE Limited, P. J. Tower,
Dalal Street, Fort,
Mumbai- 400001,
Maharashtra, India
Subject: Intimation under Regulation 29(1)(a) and 30 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
Ref Security Id: VIVANTA/ Scrip Code- 541735 ISIN: INE299W01022
Dear Sir/Madam,
Pursuant to Regulation 29(1)(a) and Regulation 30 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the
Board of Directors of the Company is scheduled to be held on Friday, 24th day of July, 2026 at
04:00 P.M. at the Registered office of the Company to transact the following business:
1) To consider and approve Unaudited Standalone and Consolidated Financial Results along
with Limited Review Report of the Company for the Quarter ended on 30th June, 2026.
2) To Authorise the Signatories for Signing the Financial Statements for the Financial Year
ended on 31st March, 2026.
3) To take note of issuance of Duplicate Share Certificate(s) in lieu of the original share
certificate(s) reported as lost/misplaced by the shareholders.
4) To take note of a Certain Business Collaboration agreements with Qness Pharmaceuticals, a
proprietorship concern with the manufacture, supply, branding and marketing of
pharmaceutical and allied products.
5) To take note of Corporate Governance Report for the Quarter ended on 30th June, 2026.
6) To take note of E-Form DPT-3 Return of Deposits for the Quarter ended on 30th June, 2026.
7) Any other business with the permission of the Chair.
As per Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, Notice of the Board meeting would be made available on the website of the
company at: https://vivantaindustries.com/disclosure/
Further, as already informed, as per the SEBI (Prohibition of Insider Trading) Regulations,
2015 as amended from time to time, and Company's Internal Code for Prohibition of Insider
Trading ('Code'), the trading window for dealing in the securities of the Company for the
Directors/Officers & Key Managerial Personnel and Designated Persons of the Company
defined under the Code has already been closed till the expiry of 48 hours after the declaration
of Financial Results for the Quarter ended on 30TH June, 2026.
We request you to take the same on record.
Thanking you,
For Vivanta Industries Limited
Hemant Amrish Parikh
Managing Director
DIN: 00027820